You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A Stanford bioengineer has created a device to sequence a single bacterial cell's genome.
A blogger discusses the concept of "wrongful birth" -- a legal issue picking up steam as in utero genetic testing becomes more commonplace.
VCs are pouring record amounts of money into the life sciences industry this year, including biotech, medical devices, and healthcare.
A blogger continues her discussion of different careers in biotechnology.
It had to happen at some point: Jonathan Eisen reports that in the past week, the Bush administration has been good to biology.
After eight years, two trials, a death sentence, and much bargaining, the six medical workers held in Libya are free.
Missouri law protects stem cell research but does not fund it.
Scientists create mice that can resist and reverse symptoms of Alzheimer's disease.
Epigenetics finally gets the limelight on the ScienceNow show on PBS.
Paper authors say Cyanidioschyzon merolae is the first completely sequenced eukaryote, but a blogger disagrees.
As medicine reaches a whole new stage thanks to genomics, medical ethics is facing a "2.0" version of its own, says the Personal Genome blog.
Genomic experts descend on NPR for a session on how DNA variation has been implicated in common diseases.
Esther Dyson explains her reasoning for joining George Church's Personal Genome Project and the rationale behind making her genome sequence and full medical records public.
IHT profiles Steven Nissen, the scientist who made a name for himself with his warnings about safety problems in drugs like Vioxx and Avandia.
Science reports on the National Plant Genome Initiative, Arabidopsis genetic variation, miRNAs, and more.
PLoS One opens up a rating system for its papers, and Jonathan Eisen has a blog post on using it.
Groups from ABRF and NIH are looking for community feedback on initiatives regarding DNA variation and proteomics.
This blog post from The Questionable Authority tries to clear up the confusion over the scientifically-subscribed-to Adam and Eve, who are not quite the Garden of Eden couple people have in mind.
Several articles look at the culture of scientific and technological innovation in the US.
Two genome-wide association studies find genes associated with coronary artery disease.
Nature looks at patents, stem cells, atrial fibrillation, and more.
A Christian extremist sends death threats to evolutionary biology professors in Boulder.
A blogger discusses a new breast cancer diagnostic test.
Two open access articles in this week's PNAS report on Parkinson's disease and single-feature polymorphisms in Arabidopsis thaliana.
The five technologies a blogger would like to have.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.